Insider · CIK 0001657070
Thomas David Hull III
Files at KEQU (KEWAUNEE SCIENTIFIC CORP /DE/). First filing Dec 27, 2024, latest Jan 8, 2026.
Thomas David Hull III files SEC Form 4 as CEO, president and director at KEQU (KEWAUNEE SCIENTIFIC CORP /DE/). Since Dec 27, 2024, Thomas David Hull III has reported 0 open-market buys worth $0 and 13 open-market sells worth $897k, the latest filed on Jan 8, 2026.
A track record needs three past buys with six months of prices behind them; Thomas David Hull III has 0, so none is measured yet.
The newest scored trade: sold $82k of KEQU on Jan 7, 2026, filed Jan 8, 2026, scored 42 (moderate). In the last 12 months: 0 buys worth $0 and 5 sells worth $218k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KEQU: KEWAUNEE SCIENTIFIC CORP /DE/
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | KEWAUNEE SCIENTIFIC CORP /DE/ | $82k 2,177 shares | -6% | +20% from low-47% from high | |
| 33Weak | KEWAUNEE SCIENTIFIC CORP /DE/ | $25k 658 shares | -2% | +20% from low-46% from high | |
| 39Weak | KEWAUNEE SCIENTIFIC CORP /DE/ | $34k 884 shares | -2% | +21% from low-46% from high | |
| 31Weak | KEQUsell KEWAUNEE SCIENTIFIC CORP /DE/ | $39k 1,000 shares | -3% | +25% from low-44% from high | |
| 31Weak | KEQUsell KEWAUNEE SCIENTIFIC CORP /DE/ | $39k 1,000 shares | -3% | +25% from low-44% from high | |
| 46Moderate | KEWAUNEE SCIENTIFIC CORP /DE/ | $43k 1,000 shares | -3% | +42% from low-37% from high | |
| 49Moderate | KEWAUNEE SCIENTIFIC CORP /DE/ | $81k 1,854 shares | -4% | +39% from low-38% from high | |
| 41Moderate | KEWAUNEE SCIENTIFIC CORP /DE/ | $75k 1,721 shares | -4% | +40% from low-38% from high | |
| 41Moderate | KEWAUNEE SCIENTIFIC CORP /DE/ | $65k 1,425 shares | -3% | +47% from low-35% from high | |
| 40Moderate | KEWAUNEE SCIENTIFIC CORP /DE/ | $60k 1,844 shares | -5% | +4% from low-54% from high | |
| 44Moderate | KEWAUNEE SCIENTIFIC CORP /DE/ | $147k 3,213 shares | -8% | - | |
| 49Moderate | KEWAUNEE SCIENTIFIC CORP /DE/ | $82k 1,368 shares | -3% | - | |
| 51Moderate | KEWAUNEE SCIENTIFIC CORP /DE/ | $126k 2,000 shares | -4% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 2, 2026 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | 2,000 0.07% of outstanding | $74k | Jan 2, 2026 | $136k |
| Dec 16, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | 3,719 0.13% of outstanding | $139k | Dec 16, 2025 | $264k |
| Sep 30, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | 1,000 0.03% of outstanding | $43k | Sep 30, 2025 | $221k |
| Sep 15, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | 5,000 0.17% of outstanding | $236k | Sep 15, 2025 | none |
| Mar 17, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | 5,057 0.18% of outstanding | $235k | Mar 17, 2025 | $208k |
| Dec 31, 2024 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | 2,129 0.07% of outstanding | $140k | Dec 31, 2024 | $126k |
| Dec 16, 2024 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | 2,000 0.07% of outstanding | $107k | Dec 16, 2024 | none |
Transactions
Every row this insider has filed, 27 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | AGrant or award Restricted Stock Units FY27derivative | +15,195 | $0.00 | $0 | 15,195 | Jun 25, 2026 |
| Jan 7, 2026 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -2,177 | $37.50 | $82k | 33,000 | Jan 8, 2026 |
| Dec 30, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -29 | $38.00 | $1,102 | 35,806 | Jan 2, 2026 |
| Dec 31, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -629 | $37.66 | $24k | 35,177 | Jan 2, 2026 |
| Dec 29, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -884 | $38.01 | $34k | 35,835 | Dec 31, 2025 |
| Dec 22, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -1,000 | $39.00 | $39k | 36,719 | Dec 23, 2025 |
| Dec 17, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -1,000 | $39.00 | $39k | 37,719 | Dec 17, 2025 |
| Oct 1, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -1,000 | $43.09 | $43k | 38,719 | Oct 2, 2025 |
| Sep 29, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -1,854 | $43.42 | $81k | 39,719 | Oct 1, 2025 |
| Sep 23, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -721 | $44.00 | $32k | 42,573 | Sep 24, 2025 |
| Sep 24, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -1,000 | $43.62 | $44k | 41,573 | Sep 24, 2025 |
| Sep 18, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -652 | $46.00 | $30k | 44,067 | Sep 22, 2025 |
| Sep 19, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -773 | $45.34 | $35k | 43,294 | Sep 22, 2025 |
| Jun 30, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | MOption exercise Common Stock | +12,130 | $0.00 | $0 | 48,202 | Jul 2, 2025 |
| Jul 1, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | FTax withholding Common Stock | -3,483 | $58.34 | $203k | 44,719 | Jul 2, 2025 |
| Jun 30, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | MOption exercise Restricted Stock Units FY23derivative | -5,357 | $0.00 | $0 | 0 | Jul 2, 2025 |
| Jun 30, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | MOption exercise Restricted Stock Units FY24derivative | -4,133 | $0.00 | $0 | 33,061 | Jul 2, 2025 |
| Jun 30, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | MOption exercise Restricted Stock Units FY25derivative | -2,640 | $0.00 | $0 | 17,166 | Jul 2, 2025 |
| Jun 25, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | AGrant or award Restricted Stock Units FY26derivative | +25,328 | $0.00 | $0 | 25,328 | Jun 27, 2025 |
| Apr 14, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -1,844 | $32.44 | $60k | 36,072 | Apr 14, 2025 |
| Mar 21, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -213 | $48.53 | $10k | 40,916 | Mar 24, 2025 |
| Mar 24, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -2,200 | $45.46 | $100k | 38,716 | Mar 24, 2025 |
| Mar 24, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -800 | $46.10 | $37k | 37,916 | Mar 24, 2025 |
| Jan 10, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -1,368 | $60.08 | $82k | 41,129 | Jan 13, 2025 |
| Dec 26, 2024 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | SOpen-market sale Common Stock | -2,000 | $63.01 | $126k | 42,497 | Dec 27, 2024 |
| Dec 16, 2024 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | GGift Common Stock | -1,000 | $0.00 | $0 | 44,497 | Dec 17, 2024 |
| Dec 13, 2024 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | GGift Common Stock | -1,000 | $0.00 | $0 | 45,497 | Dec 16, 2024 |
Questions about Thomas David Hull III
Answered from the filings on this page, as of the latest one.
Is Thomas David Hull III buying or selling?
In the last 12 months Thomas David Hull III reported 0 open-market buys worth $0 and 5 open-market sells worth $218k on SEC Form 4; the latest was sold $82k of KEQU on Jan 7, 2026. Grants, option exercises and tax withholding are not counted.
How did Thomas David Hull III's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas David Hull III has 0.
Where does Thomas David Hull III file Form 4?
Thomas David Hull III has filed Form 4 at KEQU (KEWAUNEE SCIENTIFIC CORP /DE/) as President & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.